Literature DB >> 1637222

Concomitant cardiac and pulmonary operation: the role of cardiopulmonary bypass.

K S Ulicny1, V Schmelzer, J B Flege, J C Todd, D L Mitts, D B Melvin, C B Wright.   

Abstract

To assess the safety and efficacy of concomitant pulmonary resection and cardiac operation requiring cardiopulmonary bypass, the records of 19 patients were reviewed. Eighteen patients (94.7%) presented with cardiac symptoms and were found to have pulmonary pathology of indeterminate etiology. Pulmonary resections were performed through a median sternotomy in all but 1 patient, who underwent posterolateral thoracotomy and right middle lobectomy after repositioning because dense adhesions prevented adequate dissection through the initial incision. A total of 24 resections were performed. Sixteen (66.7%) were performed on cardiopulmonary bypass. Six wedge resections (25.0%) were performed before bypass. Two lobectomies (8.3%) were performed after infusion of protamine sulfate. Nine patients (47.4%) had benign pathology, 7 (36.8%) had primary carcinoma, and 3 (15.8%) had metastatic disease. Bleeding complications occurred in 15.8% of patients (3/19). There was 1 perioperative death (5.3%), which was due to adult respiratory distress syndrome after intraoperative hemorrhage followed lobectomy for bullous disease. Another patient required lateral extension of the sternotomy during an episode of exsanguinating intraparenchymal pulmonary hemorrhage, which resulted in lobectomy, as well as costochondral and sternal osteomyelitis. A third patient required exploration for bleeding at the staple line. Postoperative complications occurred in 7 patients (36.8%) and were predominantly respiratory (5/7, 71.4%) (p = 0.006). The median postoperative hospitalization was 15 days. Although comparison of patients who underwent pulmonary resection during bypass with those who had resection either before heparinization or after protamine infusion showed no significant difference with respect to age, incidence of malignancy, operation performed, complications, postoperative hospitalization, or survival, this was probably due to the small number of patients in the study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1637222     DOI: 10.1016/0003-4975(92)91387-o

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Simultaneous cardiac operations with pulmonary resection for lung carcinoma.

Authors:  K Morishita; N Kawaharada; T Watanabe; R Koshima; Y Fujisawa; A Watanabe; K Kusajima; T Koshino; J Fukada; T Abe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

2.  Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency.

Authors:  Xuchen Ma; Fangjiong Huang; Zhitai Zhang; Feiqiang Song; Songlei Ou
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

3.  Concomitant cardiac and pulmonary operations for lung cancer.

Authors:  S La Francesca; O H Frazier; B Radovancĕvić; L F De Caro; G J Reul; D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

4.  Concomitant surgery of a left atrial myxoma and a pulmonary carcinoma.

Authors:  Kozo Nakanishi; Takashi Nagaie; Jiro Tanaka; Hiromi Ando
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-08

5.  Lung exposure during simultaneous myocardial revascularization and lung surgery through median sternotomy.

Authors:  Dariusz Jagielak; Radoslaw Kozaryn; Rafal Pawlaczyk; Piotr Siondalski; Witold Rzyman; Jan Rogowski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-12-30

6.  Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis.

Authors:  Shizhao Cheng; Yiyao Jiang; Xin Li; Xike Lu; Xun Zhang; Daqiang Sun
Journal:  J Cardiothorac Surg       Date:  2021-08-09       Impact factor: 1.637

7.  Coronary artery bypass grafting with concomitant resection for carcinoma of lung.

Authors:  Yangyang Zhang; Yanhu Wu; Biao Yuan; Xiang Liu; Sheng Zhao; Zhi Li; Yu Xia
Journal:  J Biomed Res       Date:  2010-01

Review 8.  Extracorporeal support for pulmonary resection: current indications and results.

Authors:  Petra Rosskopfova; Jean Yannis Perentes; Hans-Beat Ris; Fabrizio Gronchi; Thorsten Krueger; Michel Gonzalez
Journal:  World J Surg Oncol       Date:  2016-02-02       Impact factor: 2.754

9.  [Combined surgical intervention treatments for lung cancer and coronary heart disease patients].

Authors:  Xuchen Ma; Zhitai Zhang; Yansheng Hu; Feiqiang Song; Shaoyan Zhang; Songlei Ou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.